The combination of artesunate and veniprofen enhances the apoptosis rate of human uveal melanoma C918 and inhibits the viability of human uveal melanoma C1 cells by a mechanism that may be related to the regulation of the MALAT918/YAP signaling pathway [170]. The gene discussed is YAP1; the disease is uveal melanoma.